The findings from this study strongly suggest that considering CTLA-4 as a prospective biomarker could prove valuable in diagnosing OC while highlighting that elevated concentrations of PD-L1 and PD-1 serve as unfavorable prognostic indicators for this particular form of cancer (182). This evidence concerns the gene PDCD1 and cancer.